Publications 2010

HELLE F, VIEYRES G, ELKRIEF L, POPESCU I, WYCHOWSKI C, DESCAMPS V, CASTELAIN S, ROINGEARD P, DUVERLIE G, DUBUISSON J. Role of N-linked glycans in the function of hepatitis C virus envelope proteins incorporated into infectious virions. J Virol 2010, 84, 11905-11915.

GOUTTENOIRE J, ROINGEARD P, PENIN F, MORADPOUR F. Amphipathic alpha-helix AH2 is a major determinant for the oligomerization of hepatitis C virus nonstructural protein 4B. J Virol 2010, 84, 12529-12537.

LALLEMANT C, HALEMBOKAKA G, BATY G, NGO-GIANG-HUONG N, BARIN F, LE COEUR S. Impact of HIV-AIDS on child mortality before the highly active antiretroviral therapy era: a study in Pointe-Noire, republic of Congo. J Trop Med 2010, pII, 897176.

DESCAMPS A, CHAIX ML, MONTES B, PAKIANATHER S, CHARPENTIER C, STORTO A, BARIN F, DOS SANTOS G, KRIVINE A, DELAUGERRE C, IZOPET J, MARCELIN AG, MAILLARD A, MORAND-JOUBERT L, PALLIER C, PLANTIER JC, TAMALET C, COTTALORDA J, DESBOIS D, CALVEZ V, BRUN-VEZINET F, MASQUELIER B, COSTAGLIOLA D, on behalf of the ANRS AC11 resistance study group. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naïve chronically HIV-infected patients from 2001 to 2006/2007 in France. J Antimicrobial Chemother 2010, 65, 2620-2627.

LE VU S, LE STRAT Y, BARIN F, PILLONEL J, CAZEIN F, BOUSQUET V, BRUNET S, THIERRY D, SEMAILLE C, MEYER L, DESENCLOS J-C. Population based-HIV-1 incidence in France, 2003-08 : a modelling analysis. Lancet Infect Dis 2010, 10, 682-687.

GAUDY-GRAFFIN C, LESAGE G, KOUSIGNIAN I, LAPERCHE S, GIRAULT A, DUBOIS F, GOUDEAU A, BARIN F. Use of an anti-HCV IgG avidity assay to identify recent HCV infection. J Clin Microbiol 2010, 48, 3281-3287.

FERRARIS P, BLANCHARD E, ROINGEARD P. Ultrastructural and biochemical analyses of hepatitis c virus associated host cell membranes. J Gen Virol 2010, 91, 2230-2237.

BRAIBANT M, XIE J, SAMRI A, AGUT H, AUTRAN B, BARIN F. Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strain. Virology 2010, 405, 81-92.

DEPLA M, UZBEKOF R, HOURIOUX C, BLANCHARD E, LE GOUGE A, GILLET L, ROINGEARD P. Ultrastructural and quantitative analysis of the lipid droplet clustering induced by the hepatitis C virus core protein. Cell Mol Life Sci 2010, 67, 3151-3161.

SEMAILLE C, CAZEIN F, LOT F, PILLONEL J, LE VU S, LE STRAT Y, BOUSQUET V, VELTER A, BARIN F. Recently acquired HIV infection in men who have sex with men (MSM) in France, 2003-2008. Euro Surveill 2010, 14, e19425.

NGO-GIANG-HUOUNG N, JOURDAIN G, SIRIRUNGSI W, DECKER L, KHAMDUANG W, LE COEUR S, SIRINONTAKAN S, SOMSAMAI R, PAGDI K, HEMVUTTIPHAN J, McINTOSH K, BARIN F, LALLEMANT M. Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand. Int J Infect Dis 2010, 14, 602-607.

PIVER E, ROINGEARD P, PAGES J-C. The cell biology of Hepatitis C virus lipid addiction: molecular mechanisms and its potential importance in the clinic. Int J Biochem Cell Biol 2010, 42, 869-879.

GOUESLAIN L, ALSALEH K, HORRELOU P, ROINGEARD P, DESCAMPS V, DUVERLIE G, CICZORA Y, WYCHOWSKI C, DUBUISSON J, ROUILLE Y. Identitifation of GBF1 as a cellular factor required for hepatitis C virus RNA replication. J Virol 2010, 84, 773-787.

HAMARD-PERON E, JUILLARD F, SAAD JS, ROY C, ROINGEARD P, SUMMERS MF, DARLIX J-L, PICART C, MURIAUX D. Targeting of MuLV Gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix. J Virol 2010, 84, 503-515.